Trend·igger

moderna share price

Search on Google

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

Trending in 3 countries:

Peak volume

100+

First seen

2026-08-19

Last seen

2026-08-19

Days trending

1 / 1

Countries

3

Trending timeline

100+

Latest related news (2026-08-19)

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90% — CNBC
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial — Reuters
Moderna Soars 100%, Merck Jumps On Cancer Vaccine Trial Win — Investor's Business Daily